Tianwei Zhang

AstraZeneca R&D
Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.

The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.

Journal: Science advances
Published: January 31, 2018

Enhanced efficacy of AZD3759 and radiation on brain metastasis from EGFR mutant non-small cell lung cancer.

Enhanced efficacy of AZD3759 and radiation on brain metastasis from EGFR mutant non-small cell lung cancer.

Journal: International journal of cancer
Published: September 30, 2017

Programmed cell death ligand 1 protein levels predicted survival of non-small cell lung cancer.

Programmed cell death ligand 1 protein levels predicted survival of non-small cell lung cancer.

Journal: Journal of Cancer
Published: June 10, 2017

PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC).

PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC).

Journal: Oncotarget
Published: August 02, 2016

Intra-Tumoral Heterogeneity of HER2, FGFR2, cMET and ATM in Gastric Cancer: Optimizing Personalized Healthcare through Innovative Pathological and Statistical Analysis.

Intra-Tumoral Heterogeneity of HER2, FGFR2, cMET and ATM in Gastric Cancer: Optimizing Personalized Healthcare through Innovative Pathological and Statistical Analysis.

Journal: PloS one
Published: July 30, 2015

Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients.

Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients.

Journal: PloS one
Published: June 29, 2015

Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity.

Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity.

Journal: PloS one
Published: March 30, 2015

Oncogenic HER2 fusions in gastric cancer.

Oncogenic HER2 fusions in gastric cancer.

Journal: Journal of translational medicine
Published: December 29, 2014

Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.

Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.

Journal: BMC cancer
Published: November 05, 2014

An evaluation and recommendation of the optimal methodologies to detect RET gene rearrangements in papillary thyroid carcinoma.

An evaluation and recommendation of the optimal methodologies to detect RET gene rearrangements in papillary thyroid carcinoma.

Journal: Genes, chromosomes & cancer
Published: July 16, 2014

Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models.

Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models.

Journal: Molecular oncology
Published: June 11, 2014

A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies.

A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies.

Journal: BMC cancer
Published: March 18, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026